The pill, known only by the codename BGC20-0166, is a combination of two existing drugs that affect areas of the brain associated with muscles in the airway and airflow.
The apnoea-hypopnea index - a measure of the frequency and severity of breathing pauses through the night - was recorded in overnight studies after 14 days and again after 28 days.
Those who were taking the new pill showed a 40 per cent reduction in symptoms - with patients suffering no side-effects.
Three out of ten people on the new drug had a 50 per cent reduction in symptoms [Remedies to stop snoring].
The drug is being developed by BTG, a life sciences company based in London and Philadelphia.
Thomas Roth, director of the Sleep Disorders and Research Centre at the Henry Ford Hospital in Detroit, claims that taking a daily pill can curb a common snoring disorder affecting thousands of people.
Researchers have begun trialling a drug which helps manage obstructive sleep apnoea syndrome (OSA).
However Marianne Davey, director of the British Snoring and Sleep Apnoea Association, issued a warning. She said: “At the moment, the consensus is that there is no drug therapy that would be completely successful in treating OSA.”
Read more about this story at: http://www.dailymail.co.uk/
Related Posts:
Leave a Reply
Recent Posts
- Old People Don't Need As Much Sleep, New Study Finds
- Why Is It So Hard To Wake Up In The Morning?
- Is Co-Sleeping A Safe Option For Newborns?
- Sleep Apnea May Trigger Nighttime Heart Attacks
- New Approach Sheds Light On Ways Circadian Disruption Affects Human Health
- Too Much, Too Little Sleep Increases Ischemic Risk In Postmenopausal Women
- Are You Annoyed With Snoring? Simple Ways To Get Better Snoring Relief!
- Adolescent Weight Gain: Role Of Internet, Alcohol And Sleep
- How Menopause Is Linked To Sleep Apnea?
- Bad Affect On Learning Ability Of Children With Poor Sleep Habits